New mAB approval: Avelumab for metastatic Merkel Cell Carcinoma (mMCC)
Posted on25 Mar 2017
Comments0
Biomolecule: Avelumab Brand : Bavencio Class: Monoclonal Antibodies Sub Class: Human anti-PD-L1 antibody of isotype IgG1 USFDA approval Date: 23rd March, 2017... Read More
Pfizer, Merck KGaA, Verastem Ovarian Cancer Study Tie-Up
Pfizer Inc. PFE, Merck KGaA MKGAF and Verastem, Inc. VSTM announced that they have entered into an agreement for evaluating avelumab in... Read More